$73.92
Price
$29.0B
Market Cap
41.1
P/E Ratio
29.8
Forward P/E
$1.80
EPS (TTM)
—
Dividend Yield
$3.3B
Cash
$2.6B
Total Debt
390M
Shares Out
$54.11
$93.25
52-Week Range
Institutional Ownership of DEXCOM INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for DEXCOM INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for DEXCOM INC
6 Months Insider Sentiment
Buy $1.0M
Sell $977K
2
Buys
6
Sells
+25K
Net
1
Grants
Largest
$863K
Leach
$358K
Sylvain
$218K
Collins
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Richard Alexander Collins | Director | SELL | 2.9K | $59.05 | $172K |
| Nov 12, 2025 | Bridgette P Heller | Director | SELL | 1.0K | $58.07 | $59K |
| Nov 10, 2025 | Jacob Steven Leach | President & COO | BUY | 15.7K | $54.98 | $863K |
| Nov 10, 2025 | Jacob Steven Leach | President & COO | BUY | 2.5K | $55.43 | $139K |
| Nov 10, 2025 | Richard Alexander Collins | Director | SELL | 3.9K | $55.17 | $218K |
| Oct 24, 2025 | Euan A. Ashley | Director | GRANT | 7.2K | — | — |
| Sep 05, 2025 | Kyle Malady | Director | SELL | 667 | $80.86 | $54K |
| Sep 04, 2025 | Sadie Stern | EVP, Chief HR Officer | SELL | 1.5K | $80.00 | $117K |
| Sep 02, 2025 | Jereme M Sylvain | EVP, Chief Financal Officer | SELL | 4.8K | $74.17 | $358K |